FDA Issues Word Of Caution Over Tussionex

Law360, New York (March 11, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration has issued a strong warning regarding Tussionex in the wake of reports that the prescription cough medicine has been linked to numerous deaths and other near-fatal incidents due to misuse.

On Tuesday, the FDA alerted the public to the growing concern surrounding Tussionex, calling the drug which contains the powerful narcotic hydrocodone, a “potent” medication.

“There is a real and serious risk for overdosing if this medication is not used according to the labeling,” said Dr. Curtis Rosebraugh, acting director...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.